Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 USD | -5.54% | -9.83% | -37.92% |
Evolution of the average Target Price on Olema Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Olema Pharmaceuticals, Inc.
Goldman Sachs | |
HC Wainwright | |
Citigroup | |
JPMorgan Chase | |
Canaccord Genuity | |
Credit Suisse | |
Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- OLMA Stock
- Consensus Olema Pharmaceuticals, Inc.